Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Annals of Translational Medicine
|
January 9, 2023
Cost-effectiveness of precision molecular diagnostic tests for stage II colorectal cancer
Vivek S Chaudhari, Amalia M Issa
Cancer
|
February 24, 2012
Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model
Mo Yang, Suja Rajan, Amalia M Issa
Clinical Pharmacology in Drug Development
|
November 4, 2025
What Does an Editor Do in 2025?
Amalia M Issa, Michael Fossler, Vijay V Upreti
The British Journal of Ophthalmology
|
September 4, 2010
The quality of pharmacoeconomic evaluations of age-related macular degeneration therapeutics: a systematic review and quantitative appraisal of the evidence
William J Foster, Waqas Tufail, Amalia M Issa
Expert Review of Molecular Diagnostics
|
December 6, 2014
The value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidence
Amalia M Issa, Vivek S Chaudhari, Gary E Marchant
Personalized Medicine
|
May 18, 2018
A national study of breast and colorectal cancer patients' decision-making for novel personalized medicine genomic diagnostics
Amalia M Issa, Waqas Tufail, Nelson Atehortua, et al.
Personalized Medicine
|
July 5, 2022
Evaluating the quality of the economic evidence in colorectal cancer genomics studies
Vivek S Chaudhari, Kanchan C Hole, Amalia M Issa
Nature Reviews. Drug Discovery
|
May 24, 2006
Diagnostics and biomarker development: priming the pipeline
Kathryn A Phillips, Stephanie Van Bebber, Amalia M Issa
Personalized Medicine
|
May 12, 2018
Big data in the era of precision medicine: big promise or big liability?
Amalia M Issa, Gary E Marchant, Douglas Campos-Outcalt
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 22, 2013
The quality of economic studies of cancer pharmacogenomics: a quantitative appraisal of the evidence
Mo Yang, Dhaval S Patel, Waqas Tufail, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Annals of Translational Medicine
|
January 9, 2023
Cost-effectiveness of precision molecular diagnostic tests for stage II colorectal cancer
Vivek S Chaudhari, Amalia M Issa
Cancer
|
February 24, 2012
Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model
Mo Yang, Suja Rajan, Amalia M Issa
Clinical Pharmacology in Drug Development
|
November 4, 2025
What Does an Editor Do in 2025?
Amalia M Issa, Michael Fossler, Vijay V Upreti
The British Journal of Ophthalmology
|
September 4, 2010
The quality of pharmacoeconomic evaluations of age-related macular degeneration therapeutics: a systematic review and quantitative appraisal of the evidence
William J Foster, Waqas Tufail, Amalia M Issa
Expert Review of Molecular Diagnostics
|
December 6, 2014
The value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidence
Amalia M Issa, Vivek S Chaudhari, Gary E Marchant
Personalized Medicine
|
May 18, 2018
A national study of breast and colorectal cancer patients' decision-making for novel personalized medicine genomic diagnostics
Amalia M Issa, Waqas Tufail, Nelson Atehortua, et al.
Personalized Medicine
|
July 5, 2022
Evaluating the quality of the economic evidence in colorectal cancer genomics studies
Vivek S Chaudhari, Kanchan C Hole, Amalia M Issa
Nature Reviews. Drug Discovery
|
May 24, 2006
Diagnostics and biomarker development: priming the pipeline
Kathryn A Phillips, Stephanie Van Bebber, Amalia M Issa
Personalized Medicine
|
May 12, 2018
Big data in the era of precision medicine: big promise or big liability?
Amalia M Issa, Gary E Marchant, Douglas Campos-Outcalt
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 22, 2013
The quality of economic studies of cancer pharmacogenomics: a quantitative appraisal of the evidence
Mo Yang, Dhaval S Patel, Waqas Tufail, et al.
Page
of 6